BioPharma Drug Approval

MSD announces FDA approval of WINREVAIR™ for pulmonary arterial hypertension, introducing a novel class of therapy.

MSD, also known in the United States and Canada as Merck (NYSE: MRK), announced today the U.S. Food and Drug Administration (FDA) has granted approval for ...

 March 27, 2024 | News

DigmBio's Breakthrough Cancer Drug Clears Korean Regulatory Hurdle

BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breas...

 March 26, 2024 | News

Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL

Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL   Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...

 March 25, 2024 | News

Vertex Pharmaceuticals Receives FDA Clearance for Innovative ADPKD Drug Trial

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) f...

 March 22, 2024 | News

Oscotec Inc. Gains FDA Orphan Drug Designation for Promising ITP Treatment Cevidoplenib

Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immun...

 March 22, 2024 | News

Singapore Approves Everest Medicines' NEFEGAN® for Adult Primary IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commerc...

 March 20, 2024 | News

KeChow Pharma's Tunlametinib Receives Historic Approval in China for Advanced Melanoma Treatment

KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule therapeutics for cancer, t...

 March 19, 2024 | News

FDA Grants Fast Track Designation to ImmVira's MVR-T3011 IT for Advanced Head and Neck Cancer

ImmVira's groundbreaking oncolytic virus therapy, MVR-T3011 IT intratumoral injection, has been awarded Fast Track designation by the U.S. Food and Drug Ad...

 March 18, 2024 | News

CStone's Sugemalimab Granted Historic Approval in China for Gastric Cancer Treatment

CStone Pharmaceuticals has achieved a significant milestone with the approval of sugemalimab (Cejemly®) by the National Medical Products Administration...

 March 18, 2024 | News

BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...

 March 15, 2024 | News

FDA Approves Rezdiffra for Noncirrhotic NASH with Liver Fibrosis

U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with m...

 March 15, 2024 | News

Mirum Pharmaceuticals Announces FDA Approval of LIVMARLI for Cholestatic Pruritus in PFIC Patients

    Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leader in developing innovative treatments for rare liver diseases, has proudly announced the...

 March 14, 2024 | News

FDA Grants Nefecon® Orphan Drug Exclusivity for Seven Years

Everest Medicines licensing partner Calliditas Therapeutics AB  announced that the U.S. FDA has granted an orphan drug exclusivity period of seven yea...

 March 12, 2024 | News

Macau Poised to Be First in Asia to Approve Everest's Etrasimod for Ulcerative Colitis

Macau is on course to become the first of Everest's Asian territories to get etrasimod approval -- Can provide access to patients in China's&nbs...

 March 11, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close